McDermott Will & Emery and SRS Acquiom cordially invite you to a Life Sciences Roundtable Series entitled Structuring Milestones and Contingent Payments in Collaboration and M&A Agreements.  Please join us for this complimentary program during which SRS Acquiom will present recent data from their experience managing 100 life sciences M&A deals and our panel will address the key issues and recent trends involved in structuring milestone and contingent payments in collaboration and M&A agreements.

Our panelists will address the following critical issues related to pharmaceutical and medtech deal-making:

• Key factors to consider when structuring and drafting clinical, regulatory and sales-based milestone payments
• Drafting “due diligence” obligations, and the definition of “commercially reasonable efforts”
• Recent developments in life sciences litigation involving milestone payments, earn-outs, contingent consideration and royalty payments